We’re working on it; and a lot of progress has been made.
Not every condition has glaringly obvious signs of its presence in the body. Not every condition can use one set of markers
So the issue is two fold – which markers do we use in testing and how much commonality exists across all patients.
A test isn’t good if it’ll only work in a small number of positive cases
Latest Answers